Patent Application: Benzofuranyl/Benzoxazolyl Compounds for Cancer Treatment

ChangeBridge: Patent Apps - Organic Chemistry (C07D)

Published May 2nd, 2025

Detected March 26th, 2026

Summary

The USPTO has published a patent application (US20260085064A1) for substituted benzofuranyl and benzoxazolyl compounds, including their synthesis and use in treating cancer. The application was filed on May 2, 2025, by inventors from institutions including the University of Texas MD Anderson Cancer Center.

View original document View source feed page

What changed

This document is a published patent application from the USPTO detailing novel substituted benzofuranyl and benzoxazolyl compounds. The application, identified as US20260085064A1, specifically describes compounds and their use in treating cancer, such as mantle cell lymphoma. The filing date for this application was May 2, 2025.

As this is a patent application, it represents a request for intellectual property protection rather than a regulatory mandate. Companies involved in pharmaceutical research and development, particularly in oncology, may find this application of interest for competitive intelligence or potential licensing opportunities. There are no immediate compliance obligations or deadlines associated with this publication for regulated entities.

Source document (simplified)

← USPTO Patent Applications

SUBSTITUTED BENZOFURANYL AND BENZOXAZOLYL COMPOUNDS AND USES THEREOF

Application US20260085064A1 Kind: A1 Mar 26, 2026

Inventors

Erkan Baloglu, Sharon Shacham, William Senapedis, Dilara McCauley, Yosef Landesman, Gali Golan, Ori Kalid, Sharon Shechter

Abstract

The invention generally relates to substituted benzofuranyl and substituted benzoxazolyl compounds, and more particularly to a compound represented by Structural or a pharmaceutically acceptable salt thereof, wherein the variables are as defined and described herein. The invention also includes the synthesis and use of a compound of Structural Formula A, or a pharmaceutically acceptable salt or composition thereof, e.g., in the treatment of cancer (e.g., mantle cell lymphoma), and other diseases and disorders.